Fujian Haixi Pharmaceuticals Co., Ltd.
As of 20 November 2026, for the company name Fujian Haixi Pharmaceuticals Co., Ltd. as recorded, 11 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 34 records, across 27 drug names; since 23 August 2026, the records list Accepted: 5 applications, No longer listed under review: 2 applications (NMPA data as of 19 November 2026); the chemical-drug catalogue lists 10 active records with this name as holder.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/20.
Drug filings
34 acceptance records as first applicant, grouped into 27 source drug names. Source data as of 2026/11/20.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
枸橼酸铋钾片 · No verified English name 1 records · Latest accepted 2026/10/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602640 | Generic | 2026/10/28 | Fujian Haixi Pharmaceuticals Co., Ltd. | CDE ↗ |
Cinacalcet Hydrochloride Tablets 1 records · Latest accepted 2026/10/21
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601925 | Supplement | 2026/10/21 | Fujian Haixi Pharmaceuticals Co., Ltd.; Guangdong An Nuo Pharma Co., Ltd. romanized | CDE ↗ |
布美他尼片 · No verified English name 1 records · Latest accepted 2026/10/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602476 | Generic | 2026/10/10 | Fujian Haixi Pharmaceuticals Co., Ltd. | CDE ↗ |
HX9428片 · No verified English name 4 records · Latest accepted 2026/09/08
New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2601091 | New drug | 2026/09/08 | Fujian Haixi Pharmaceuticals Co., Ltd. | CDE ↗ |
| CXHL2601090 | New drug | 2026/09/08 | Fujian Haixi Pharmaceuticals Co., Ltd. | CDE ↗ |
| CXHL2500117 | New drug | 2025/01/25 | Fujian Haixi Pharmaceuticals Co., Ltd. | CDE ↗ |
| CXHL2500116 | New drug | 2025/01/25 | Fujian Haixi Pharmaceuticals Co., Ltd. | CDE ↗ |
Teprenone Capsules 1 records · Latest accepted 2026/07/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601749 | Generic | 2026/07/21 | Fujian Haixi Pharmaceuticals Co., Ltd. | CDE ↗ |
Tizanidine Hydrochloride Tablets 1 records · Latest accepted 2026/07/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601613 | Generic | 2026/07/07 | Fujian Haixi Pharmaceuticals Co., Ltd. | CDE ↗ |
Doxycycline Hyclate Tablets 1 records · Latest accepted 2026/06/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601459 | Generic | 2026/06/22 | Fujian Haixi Pharmaceuticals Co., Ltd. | CDE ↗ |
HX1408片 · No verified English name 2 records · Latest accepted 2026/05/12
New drug · 2
腺苷钴胺胶囊 · No verified English name 2 records · Latest accepted 2026/04/09
Supplement · 1Generic · 1
Deferasirox Tablets 1 records · Latest accepted 2026/02/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600454 | Generic | 2026/02/12 | Fujian Haixi Pharmaceuticals Co., Ltd. | CDE ↗ |
Lercanidipine Hydrochloride Tablets 1 records · Latest accepted 2026/01/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600050 | Generic | 2026/01/06 | Fujian Haixi Pharmaceuticals Co., Ltd. | CDE ↗ |
Iguratimod Tablets 1 records · Latest accepted 2026/01/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600049 | Generic | 2026/01/06 | Fujian Haixi Pharmaceuticals Co., Ltd. | CDE ↗ |
Pinaverium Bromide Tablets 1 records · Latest accepted 2025/12/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504367 | Generic | 2025/12/24 | Fujian Haixi Pharmaceuticals Co., Ltd. | CDE ↗ |
Polaprezinc Granules 1 records · Latest accepted 2025/08/04
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502808 | Generic | 2025/08/04 | Fujian Haixi Pharmaceuticals Co., Ltd.; Guangdong An Nuo Pharma Co., Ltd. romanized | CDE ↗ |
Paracetamol and Ibuprofen Tablets 1 records · Latest accepted 2025/05/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501818 | Generic | 2025/05/20 | Fujian Haixi Pharmaceuticals Co., Ltd.; Zhejiang Hua Run San Jiu Zhong Yi Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Pentoxifylline Modified Release Tablets 1 records · Latest accepted 2025/01/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500310 | Generic | 2025/01/15 | Fujian Haixi Pharmaceuticals Co., Ltd.; Guangdong An Nuo Pharma Co., Ltd. romanized | CDE ↗ |
Benidipine Hydrochloride Tablets 1 records · Latest accepted 2024/05/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401585 | Generic | 2024/05/28 | Fujian Haixi Pharmaceuticals Co., Ltd.; Guangdong An Nuo Pharma Co., Ltd. romanized | CDE ↗ |
Cetitizine Hydrochloride Oral Solution 1 records · Latest accepted 2023/12/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303555 | Generic | 2023/12/21 | Fujian Haixi Pharmaceuticals Co., Ltd.; Hua Yi Tai Kang Pharma Co., Ltd. romanized | CDE ↗ |
Sodium Valproate Sustained-release Tablets(I) 1 records · Latest accepted 2023/09/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302527 | Generic | 2023/09/19 | Fujian Haixi Pharmaceuticals Co., Ltd.; Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | CDE ↗ |
Bisoprolol Fumarate and Amlodipine Besylate Tablets 1 records · Latest accepted 2023/08/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302208 | Generic | 2023/08/22 | Fujian Haixi Pharmaceuticals Co., Ltd.; Guangdong An Nuo Pharma Co., Ltd. romanized | CDE ↗ |
Agomelatine Tablets 1 records · Latest accepted 2023/07/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302023 | Generic | 2023/07/28 | Fujian Haixi Pharmaceuticals Co., Ltd.; Guangdong An Nuo Pharma Co., Ltd. romanized | CDE ↗ |
Amlodipine Besylate and Atorvastatin Calcium Tablets 2 records · Latest accepted 2023/06/03
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301279 | Supplement | 2023/06/03 | Fujian Haixi Pharmaceuticals Co., Ltd.; Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2301278 | Supplement | 2023/06/03 | Fujian Haixi Pharmaceuticals Co., Ltd.; Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | CDE ↗ |
C019199片 · No verified English name 2 records · Latest accepted 2023/02/11
New drug · 2
Diclofenac Sodium Enteric-coated Tablets 1 records · Latest accepted 2023/01/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300232 | Generic | 2023/01/29 | Fujian Haixi Pharmaceuticals Co., Ltd.; Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | CDE ↗ |
瑞巴派特片 · No verified English name 1 records · Latest accepted 2022/12/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2202087 | Generic | 2022/12/21 | Fujian Haixi Pharmaceuticals Co., Ltd.; Guangdong An Nuo Pharma Co., Ltd. romanized | CDE ↗ |
Hydroxychloroquine Sulfate Tablets 1 records · Latest accepted 2022/07/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201108 | Generic | 2022/07/20 | Fujian Haixi Pharmaceuticals Co., Ltd.; Fu An Pharma Group Qing Yu Tang Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Nicergoline Tablets 1 records · Latest accepted 2022/06/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200980 | Generic | 2022/06/30 | Fujian Haixi Pharmaceuticals Co., Ltd.; ZHEJIANG JINGXIN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Changes in the last 90 days
7 events from 2026/08/23 to 2026/11/20. CDE data as of 2026/11/20; NMPA data as of 2026/11/19.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Accepted: 5 applicationsNo longer listed under review: 2 applications
- 2026/11/18No longer listed under review
HX9428片 · No verified English name
CXHL2601091
Fact date: 2026/11/18 · Date added to this site: 2026/11/18
Accepted: 2026/09/08
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/11/18No longer listed under review
HX9428片 · No verified English name
CXHL2601090
Fact date: 2026/11/18 · Date added to this site: 2026/11/18
Accepted: 2026/09/08
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/10/28Accepted
枸橼酸铋钾片 · No verified English name
CYHS2602640
Fact date: 2026/10/28 · Date added to this site: 2026/10/29
View source ↗ - 2026/10/21Accepted
Cinacalcet Hydrochloride Tablets
CYHB2601925
Fact date: 2026/10/21 · Date added to this site: 2026/10/22
View source ↗ - 2026/10/10Accepted
布美他尼片 · No verified English name
CYHS2602476
Fact date: 2026/10/10 · Date added to this site: 2026/10/22
View source ↗ - 2026/09/08Accepted
HX9428片 · No verified English name
CXHL2601091
Fact date: 2026/09/08 · Date added to this site: 2026/10/22
View source ↗ - 2026/09/08Accepted
HX9428片 · No verified English name
CXHL2601090
Fact date: 2026/09/08 · Date added to this site: 2026/10/22
View source ↗
Under review
11 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/20.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 枸橼酸铋钾片 · No verified English name | CYHS2602640 | Generic | 2026/10/28 | Fujian Haixi Pharmaceuticals Co., Ltd. | CDE ↗ |
| Cinacalcet Hydrochloride Tablets | CYHB2601925 | Supplement | 2026/10/21 | Fujian Haixi Pharmaceuticals Co., Ltd.; Guangdong An Nuo Pharma Co., Ltd. romanized | CDE ↗ |
| 布美他尼片 · No verified English name | CYHS2602476 | Generic | 2026/10/10 | Fujian Haixi Pharmaceuticals Co., Ltd. | CDE ↗ |
| Teprenone Capsules | CYHS2601749 | Generic | 2026/07/21 | Fujian Haixi Pharmaceuticals Co., Ltd. | CDE ↗ |
| Tizanidine Hydrochloride Tablets | CYHS2601613 | Generic | 2026/07/07 | Fujian Haixi Pharmaceuticals Co., Ltd. | CDE ↗ |
| Doxycycline Hyclate Tablets | CYHS2601459 | Generic | 2026/06/22 | Fujian Haixi Pharmaceuticals Co., Ltd. | CDE ↗ |
| Deferasirox Tablets | CYHS2600454 | Generic | 2026/02/12 | Fujian Haixi Pharmaceuticals Co., Ltd. | CDE ↗ |
| Lercanidipine Hydrochloride Tablets | CYHS2600050 | Generic | 2026/01/06 | Fujian Haixi Pharmaceuticals Co., Ltd. | CDE ↗ |
| Iguratimod Tablets | CYHS2600049 | Generic | 2026/01/06 | Fujian Haixi Pharmaceuticals Co., Ltd. | CDE ↗ |
| Polaprezinc Granules | CYHS2502808 | Generic | 2025/08/04 | Fujian Haixi Pharmaceuticals Co., Ltd.; Guangdong An Nuo Pharma Co., Ltd. romanized | CDE ↗ |
| Paracetamol and Ibuprofen Tablets | CYHS2501818 | Generic | 2025/05/20 | Fujian Haixi Pharmaceuticals Co., Ltd.; Zhejiang Hua Run San Jiu Zhong Yi Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Catalogue holder records
10 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/20. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | NMPA approval no. | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Pentoxifylline Modified Release Tablets | Fujian Haixi Pharmaceuticals Co., Ltd. | Guangdong An Nuo Pharma Co., Ltd. romanized | 国药准字H20264886 | 2026/06/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Benidipine Hydrochloride Tablets | Fujian Haixi Pharmaceuticals Co., Ltd. | Guangdong An Nuo Pharma Co., Ltd. romanized | 国药准字H20255076 | 2025/07/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bisoprolol Fumarate and Amlodipine Besylate Tablets | Fujian Haixi Pharmaceuticals Co., Ltd. | Guangdong An Nuo Pharma Co., Ltd. romanized | 国药准字H20249542 | 2024/12/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Agomelatine Tablets | Fujian Haixi Pharmaceuticals Co., Ltd. | Guangdong An Nuo Pharma Co., Ltd. romanized | 国药准字H20249011 | 2024/09/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 腺苷钴胺胶囊 · No verified English name | Fujian Haixi Pharmaceuticals Co., Ltd. | Guangdong An Nuo Pharma Co., Ltd. romanized | 国药准字H20244639 | 2024/08/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Diclofenac Sodium Enteric-coated Tablets | Fujian Haixi Pharmaceuticals Co., Ltd. | Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | 国药准字H20244225 | 2024/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 瑞巴派特片 · No verified English name | Fujian Haixi Pharmaceuticals Co., Ltd. | Guangdong An Nuo Pharma Co., Ltd. romanized | 国药准字H20243604 | 2024/04/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Amlodipine Besylate and Atorvastatin Calcium Tablets | Fujian Haixi Pharmaceuticals Co., Ltd. | Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | 国药准字H20247071 | 2024/04/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Hydroxychloroquine Sulfate Tablets | Fujian Haixi Pharmaceuticals Co., Ltd. | Fu An Pharma Group Qing Yu Tang Pharmaceutical Co., Ltd. romanized | 国药准字H20234411 | 2023/10/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nicergoline Tablets | Fujian Haixi Pharmaceuticals Co., Ltd. | ZHEJIANG JINGXIN PHARMACEUTICAL CO.,LTD. | 国药准字H20234574 | 2023/11/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
0 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/20.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | |||||
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
0 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/20.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | |||||
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/20
- Chemical-drug catalogue
- Last successful update: 2026/11/20
- API registrations
- Last successful update: 2026/11/20
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.